On ECHEMI
Home > Drugs > Oxaprozin Enteric-coated Tablets

Oxaprozin Enteric-coated Tablets

Function and Efficacy

It has anti-inflammatory, analgesic and antipyretic effects. It is an inhibitor of cyclooxygenase and thus inhibits the biosynthesis of prostaglandins. It has a mild effect on digestive tract damage and its efficacy is long-lasting.

Ingredients

The main ingredient of this product is: Oxaprozin. Its chemical name is: 4,5-diphenyloxazole-2-propionic acid. Molecular formula: C18H15NO3 Molecular weight: 293.32

Name Description Content CAS NO. Manufacturer
OxaprozinIngredients

It has anti-inflammatory, analgesic and antipyretic effects. It is an inhibitor of cyclooxygenase and thus inhibits the biosynthesis of prostaglandins. It has a mild effect on digestive tract damage and its efficacy is long-lasting.

More
21256-18-8 14

Appearance

White or off-white tablets, odorless or with a slight peculiar odor, slightly bitter taste.

Indication

It is suitable for rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, periarthritis of shoulder, cervical shoulder and wrist syndrome, gout, and post-traumatic and post-operative analgesia.

Usage and Dosage

Oral administration, 0.2-0.4g (1-2 tablets) at a time, once a day, for more than 1 week or as directed by a doctor, after meals, the maximum dose is 0.6g (3 tablets) per day.

Precautions

Patients with peptic ulcer, severe liver and kidney diseases, patients allergic to other non-steroidal anti-inflammatory analgesics, patients with blood diseases, children, and pregnant and lactating women.

Special Population Medication

Precautions for children: Forbidden. Precautions for pregnancy and lactation: Forbidden. Precautions for the elderly: Elderly patients are prone to adverse reactions due to decreased liver and kidney function, so they should be used with caution or in a reduced dosage.

Drug Interactions

1. The combined use of this product with aspirin may increase the toxicity of aspirin because this product can replace salicylates bound to plasma proteins; 2. In the elderly and those with decreased renal function, it will reduce the clearance rate of digoxin, increase the blood concentration of the drug and increase its toxicity; 3. When used in large doses to treat tumors, it will affect the excretion of methotrexate, increase the blood concentration of methotrexate and cause poisoning; 4. It will affect the antihypertensive effect of antihypertensive drugs (angiotensin converting enzyme inhibitors and beta-receptor inhibitor blockers); 5. It will reduce the diuretic and sodium excretion effects of diuretics.

Storage

Keep away from light and store in sealed container.

Packaging Specification

0.2g

Validity Period

36 months.

Manufacturer

Wuhan Tongji Modern Pharmaceutical Technology Co., Ltd.

  • Founded in:

    2000-12-26
  • Address:

    No. 22, High-tech Industrial Park, Wuhan Economic and Technological Development Zone
  • Tax NO.:

    91420100725762555E
  • Registered Funds:

    156.855506 yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.